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Materials and Methods
• HeyA8 are high grade ovarian serous adenocarcinoma
human cell lines used in this study.

• Understanding underlying mechanisms of ovarian cancer
will help in developing better treatments.

• Metabolites are extracted from cancer cells using a
methanol-water mixture, ceramic beads, three cycles of a
mechanical homogenization and freeze-thawing process
followed by centrifugation, rotary evaporation and
lyophilization.

• Recently, it has been found that ovarian cancer patients
with poor prognosis’ have presented with elevated stress
hormones.

• The samples are prepared for nuclear magnetic resonance
(NMR) spectroscopy by dissolving the sample in 2H2O
containing the reference compound 4,4-dimethyl-4silapentane-1-sulfonic acid-d6 (DSS).

• This study was designed to find out the metabolic
changes in ovarian cancer cells (HeyA8) when treated
with a stress hormone cortisol.
• To study this, NMR spectroscopy has been employed as
an analytical tool.

• All the data was acquired on a Bruker NMR spectrometer
operating at 500 MHz 1H resonance equipped with a
cryogenically cooled triple resonance (1H, 13C, 15N)
TXI probe.

Hypothesis: Ovarian cancer cells treated with stress
hormones show altered metabolism.

.
• Identification of metabolite peaks was done through
Chenomx and the Human Metabolomic Database
(HMDB); finally, the peaks were integrated in Topspin
and normalized to the reference compound (DSS). All 1D proton NMR spectra were normalized to the cell count
before analysis.
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• Ovarian cancer is the fifth most common cause of death
in women.
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Figure 3: Metabolites altered significantly in cortisol treated cells are
shown in the 1D 1H spectrum

Conclusions
• Initial studies showed a difference in metabolites
glutamate, guanosine and uridine.
• However, more samples need to be analyzed to obtain
statistical significance.
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